Close
CDMO Safety Testing 2026
Novotech

Mannatech adds vitamin D to omega-3 supplement

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery

QIAGEN's Digital Insights bioinformatics division is set to integrate...

AstraZeneca’s Baxfendy Wins FDA Approval for Uncontrolled Hypertension

AstraZeneca's hypertension drug baxdrostat, branded as Baxfendy, has received...
- Advertisement -

Mannatech, a developer and provider of nutritional supplements and skin care products based on Real Food Technology solutions, has added vitamin D to its omega-3 supplement. The new Omega-3 with Vitamin D3 capsules now comprise 830 IUs of vitamin D3 and continue to provide more than 1,000mg of concentrated EPA and DHA fatty acids.Mannatech’s decision to add vitamin D to its popular omega-3 supplement was prompted by expanding scientific research documenting the extensive health benefits of vitamin D.

Mannatech co-CEO and chief science officer Robert Sinnott said by adding vitamin D to their omega-3 supplement at no additional charge, they are making it easier for consumers to meet the recommended intake of the essential nutrients their bodies need but often don’t receive through a modern Western diet.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

QIAGEN and NVIDIA Join Forces to Advance AI-Driven Drug Discovery

QIAGEN's Digital Insights bioinformatics division is set to integrate...

AstraZeneca’s Baxfendy Wins FDA Approval for Uncontrolled Hypertension

AstraZeneca's hypertension drug baxdrostat, branded as Baxfendy, has received...

EU Advances Critical Medicines Act to Cut Import Reliance

The European Union has moved closer to implementing new...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป